1-3 of 3
Mansour Alfayez
Close
Sort by
Journal Articles

Cigarette smoke exposure accelerates AML progression in FLT3-ITD models

Clinical Trials & Observations
Mary Figueroa, Huaxian Ma, Mansour Alfayez, Daniel Enrique Morales-Mantilla, Fei Wang, Yue Lu, Marcos R. Estecio, Katherine Y. King, Eugenie Kleinerman, Seyed Javad Moghaddam, Naval Daver, Michael Andreeff, Marina Konopleva, Courtney DiNardo, Joya Chandra
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6624–6629.
https://doi.org/10.1182/bloodadvances.2023010111
Published: 2023
Includes: Supplemental data
Journal Articles

Single-cell polyfunctional proteomics of CD4 cells from patients with AML predicts responses to anti–PD-1–based therapy

Hussein A. Abbas, Zoe Alaniz, Sean Mackay, Matthew Cyr, Jing Zhou, Ghayas C. Issa, Mansour Alfayez, Jairo Matthews, Steven M. Kornblau, Elias Jabbour, Guillermo Garcia-Manero, Marina Konopleva, Michael Andreeff, Naval Daver
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4569–4574.
https://doi.org/10.1182/bloodadvances.2021004583
Published: 2021
Includes: Supplemental data
Journal Articles

Outcome of patients with IDH1/2- mutated post–myeloproliferative neoplasm AML in the era of IDH inhibitors

Clinical Trials & Observations
Helen T. Chifotides, Lucia Masarova, Mansour Alfayez, Naval Daver, Yesid Alvarado, Elias Jabbour, Marina Konopleva, Hagop M. Kantarjian, Keyur P. Patel, Courtney D. DiNardo, Srdan Verstovsek
Journal: Blood Advances
Blood Adv (2020) 4 (21): 5336–5342.
https://doi.org/10.1182/bloodadvances.2020001528
Published: 2020